Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses
Akhtar, Marjahan, Chowdhury, Mohiul I, Bhuiyan, Taufiqur R, Kaim, Joanna, Ahmed, Tasnuva, Rafique, Tanzeem A, Khan, Arifuzzaman, Rahman, Sadia I.A, Khanam, Farhana, Begum, Yasmin A, Sharif, Mir Z, Islam, Laila N, Carlin, Nils, Maier, Nicole, Fix, Alan, Wierzba, Thomas F, Walker, Richard I, Bourgeois, A. Louis, Svennerholm, Ann-Mari, Qadri, Firdausi, Lundgren, Anna
Published in Vaccine (03.09.2019)
Published in Vaccine (03.09.2019)
Get full text
Journal Article
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
Qadri, Firdausi, Akhtar, Marjahan, Bhuiyan, Taufiqur R, Chowdhury, Mohiul I, Ahmed, Tasnuva, Rafique, Tanzeem A, Khan, Arifuzzaman, Rahman, Sadia I A, Khanam, Farhana, Lundgren, Anna, Wiklund, Gudrun, Kaim, Joanna, Löfstrand, Madeleine, Carlin, Nils, Bourgeois, A Louis, Maier, Nicole, Fix, Alan, Wierzba, Thomas, Walker, Richard I, Svennerholm, Ann-Mari
Published in The Lancet infectious diseases (01.02.2020)
Published in The Lancet infectious diseases (01.02.2020)
Get full text
Journal Article